SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-247170
Filing Date
2020-09-16
Accepted
2020-09-16 16:07:58
Documents
3
Effectiveness Date
2020-09-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A d899312ddefa14a.htm DEFA14A 17593
2 GRAPHIC g899312g32k36.jpg GRAPHIC 7298
3 GRAPHIC g899312g75j44.jpg GRAPHIC 3309
  Complete submission text file 0001193125-20-247170.txt   33526
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38536 | Film No.: 201178934
SIC: 2834 Pharmaceutical Preparations